Document is current
Any future updates will be listed below
-
Authors
Pancholi, Sunil https://orcid.org/0000-0002-0880-1588
Ribas, Ricardo
Simigdala, Nikiana
Schuster, Eugene
Nikitorowicz-Buniak, Joanna
Ressa, Anna
Gao, Qiong https://orcid.org/0000-0002-0406-1594
Leal, Mariana Ferreira
Bhamra, Amandeep
Thornhill, Allan
Morisset, Ludivine
Montaudon, Elodie
Sourd, Laura
Fitzpatrick, Martin
Altelaar, Maarten https://orcid.org/0000-0001-5093-5945
Johnston, Stephen R.
Marangoni, Elisabetta
Dowsett, Mitch https://orcid.org/0000-0003-4122-744X
Martin, Lesley-Ann
-
Funding
Funding for this research was provided by:
Pfizer
Breast Cancer Now
- License Information
-
More Information
Article History
Received: 24 May 2019
Revised: 18 March 2020
Accepted: 24 March 2020
First Online: 19 April 2020
Compliance with ethical standards
:
: SRJ, MD and LAM receive academic funding from Pfizer, Puma Biotechnology Inc. and AstraZeneca. MD receives honoraria from Myriad Genetics and speaker’s bureau of Roche, is a consultant and advisory board member of Radius, GTx and Orion Pharma and has received remuneration from the ICR rewards to Inventors Schemes. SRJ is a consultant/independent contractor for AstraZeneca, Novartis, Pfizer, OBI, Eli Lilly and Company and is on the speaker’s bureau for OBI and Puma. No potential conflict of interests was disclosed by the other authors.
